Title : Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide.

Pub. Date : 2000 Sep

PMID : 11061606






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSIONS: Octreotide LAR 20 mg shows significant efficacy in terms of objective response rate (PR + SD), biochemical and symptomatic control in patients with metastatic NETs of the GEP system pretreated and progressing on slow release lanreotide. Octreotide granulin precursor Homo sapiens